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Abstract
Background: Oxidative stress produced by reactive oxygen species (ROS) has been linked to the development of
several diseases such as cardiovascular, cancer, and neurodegenerative diseases. This study investigates the possible
protective effect of extra virgin olive oil (EVOO), lipophilic fraction (OOLF) and hydrophilic fraction (OOHF) on
oxidative stress and fatty acid profile of erythrocytes in 2,4-D treated rats.
Methods: Male Wistar rats were divided randomly into eight groups: control (C), (2,4-D) at a dose of 5 mg/kg b.w.,
(2,4-D/EVOO) was given 2,4-D plus EVOO, (2,4-D/OOHF) that received 2,4-D plus hydrophilic fraction, (2,4-D/OOLF)
treated with 2,4-D plus lipophilic fraction, (EVOO) that received only EVOO, (OOHF) was given hydrophilic fraction
and (OOLF) treated with lipophilic fraction. These components were daily administered by gavages for 4 weeks.
Results: 2,4-D treatment lead to decrease of antioxidant enzyme activities, namely, superoxide dismutase (SOD),
catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) associated with a higher amount of
MDA level. Erythrocyte membranes’ fatty acid composition was also significantly modified with 2,4-D exposure.
EVOO and hydrophilic fraction supplemented to rats with or not 2,4-D treatment enhanced the antioxidant
enzyme activities and reduced the MDA level. However, lipophilic fraction did not show any improvement in
oxidative damage induced by 2,4-D in spite its richness in MUFA and vitamins.
Conclusion: EVOO administered to 2,4-D-treated rats protected erythrocyte membranes against oxidative damage
by means of preventing excessive lipid peroxidation to increase the MUFA composition and increase maintaining
antioxidants enzymes at normal concentrations.
Background
Oxidative stress produced by free radicals has been
linked to the development of several diseases such as
cardiovascular, cancer, and neurodegenerative diseases
[1]. However, reactive oxygen species (ROS) are con-
stantly formed as by-products of normal metabolic reac-
tions and their formation is accelerated by accidental
exposure to occupational chemicals like pesticides. Since
2,4-D (2,4-dichlorophenoxyacetic acid) is a common
herbicide used around the home and garden, on golf
courses, ball fields, parks, in agriculture and forestry.
Several reports have shown that 2, 4-D produces oxida-
tive stress and/or depletes antioxidants both in vitro and
in vivo. In vitro, studies have mainly dealt with the effect
of the herbicide on hepatocytes and red blood cells
[2-6], while in vivo oxidative activity has been proved in
different species including yeast [7,8], fish [9,10] and
rats [11].
Recently, there is growing evidence that ROS contri-
bute to organ injury in many systems including heart,
liver and central nervous system [12]. Erythrocytes are
permanently in contact with potentially damaging levels
of oxygen, but their metabolic activity is capable of
reversing this injury under normal conditions. Erythro-
cytes are equipped by many defence systems represent-
ing their antioxidant capacity [13]. This protective
system includes superoxide dismutase (SOD), catalase
(CAT), reduced glutathione, glutathione peroxidase
(GPx), glutathione-S-transferase, and glutathione
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any medium, provided the original work is properly cited.reductase (GR). However, the cellular antioxidant action
is reinforced by the presence of dietary antioxidants.
Olive oil is the main source of fat in the Mediterra-
nean diet, which has been shown to be effective against
oxidative stress associated diseases. It has been reported
also that olive oil is able to reduce the risk of coronary
heart disease (CHD) by decreasing levels of artery-clog-
ging lipids in the blood [14]. Other Studies have shown
that olive oil offers protection against heart disease by
controlling LDL ("bad” cholesterol) levels while raising
HDL (the “good” cholesterol) levels [15]. In fact, the
beneficial effects of olive oil on CHD risk have been
attributed to its high monounsaturated fatty acid
(MUFA) content, mostly in the form of oleic acid
(18:1n-9), which ranges from 70 to 80% of total fatty
acids [16]. Nevertheless, evidences have accumulated on
the beneficial properties of minor though highly bioac-
tive components of olive oil [17,18].
MUFA-enriched diets have shown no long-term ill
effects and are associated with reduced rates of CHD.
Furthermore, replacement of saturated fatty acids (SFAs)
with MUFA-enriched diets appears to have beneficial
effects on lipoprotein concentrations in both diabetic
[19] and nondiabetic persons [20]. Moreover, in Nonal-
coholic Fatty Liver Disease (NAFLD), exposure of mur-
ine or human hepatocytes to MUFA resulted in lipid
accumulation without changes in cell viability, while cell
incubation with SFAs significantly decreased cell viabi-
lity and increased caspase activation and apoptosis [21].
Healthy effects of dietary MUFA were also attributed
to decreased endothelial activation [22,23] and tendency
of LDL to oxidation [24]. Likewise, epidemiological stu-
dies showed an inverse correlation between the intake
of long-chain n-3 polyunsaturated fatty acids (PUFA)
present in fish and fish oil and the incidence of CHD
[25]. However, there are controversial reports on the
cellular and molecular mechanisms involved in these
preventive effects. Previous studies [26,27] have shown
that enrichment of the diet with MUFA at the expense
of PUFA led to LDLs that were less susceptible to oxi-
dation, as determined by in vitro assays. In fact, further
studies in vitro suggested that lipoproteins enriched
with oleic acid are less susceptible to oxidation than
those enriched with linoleic or arachidonic acid and
may have less proinflammatory activity when exposed to
oxidizing conditions [28]. Hence, oxidative stress is a
process that mainly affects structural lipids especially
PUFA. Furthermore, oxidative stress could play an
important role in the modulation of the liver fatty acid
desaturase activity [29]. Recent studies showed that
hepatic lipotoxicity include abnormal fatty acid oxida-
tion with formation of ROS and disturbances in cellular
membrane fatty acid and phospholipid composition [30].
Limited evidence from animal studies suggests that
MUFA-rich membranes are more resistant to oxidative
processes, protecting the aged cell [31,32]. Moreover,
mitochondrial structure, integrity and DNA stability to
oxidation were also enhanced when rats consumed a
extra virgin olive oil (EVOO) rich diet [32].
The beneficial effects of olive oil in the Mediterranean
diet can be attributed not onlyt ot h ec l o s er e l a t i o n s h i p
between unsaturated and saturated fatty acids, but also
to the antioxidant property of its phenolic compounds.
So, the main antioxidants of EVOO are carotenoids and
phenolic compounds, which are both lipophilic and
hydrophilic. The lipophilics include tocopherols, while
the hydrophilics include flavonoids, phenolic alcohols
and acids, secoiridoids and their metabolites. However,
the antioxidant properties of the phenolic compounds of
olive oil have been the most extensively studied. In
experimental studies, olive oil phenolic compounds,
showed strong antioxidant properties against lipids,
DNA, and LDL oxidation [33,34]. In animal models,
olive oil phenolics retained their antioxidant properties
in vivo [35] and delayed the progression of atherosclero-
sis [36]. Its other ways as result evident that b-sitosterol
and the polyphenols in olive oil (oleuropein, tyrosol,
hydroxytyrosol, and caffeic acid) inhibit the formation of
oxygen reactive species [37,38], reduce the susceptibility
of LDL oxidation, erythrocyte membranes to lipid per-
oxidation [39,40], and increase the lag time of conju-
gated diene formation in a concentration-dependent
manner [41]. Hence, most of these studies have been
performed in vitro and literature data on olive oil poly-
phenols mainly concern purified compounds. While the
total fraction antioxidant properties of the lipophilic or
hydrophilic components has been poorly investigated.
Being a complex mixture of compounds, the measure of
the total antioxidant capacity could be more representa-
tive than the protective effect of a single component.
Thus, the aim of this study was to investigate the
effects of extra virgin olive oil and its lipophilic and
hydrophilic fractions on oxidative stress and fatty acid
composition of erythrocytes in 2,4-D treated rats.
Results
Analytical parameters of extra virgin olive oil and its
compounds
The analytical parameters fatty acid, oxidative stability
and antioxidant composition of the olive oils employed
i ss h o w ni nT a b l e1 .I tc a nb es e e nt h a tt h ep h e n o l i c
compounds were efficiently removed from EVOO, being
much reduced in the olive oil lipophilic fraction
(OOLF). The procedure employed to produce the
OOLF, at variance with a washing process, has been
developed to eliminate selectively hydrophilic sub-
stances, such as phenolic compounds, leaving the other
olive oil components unmodified such as tocopherols
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fraction (OOHF) contained only phenolic compounds
(384 mg/kg).
Erythrocyte oxidative damage
All the results from various treatment groups were com-
pared with their normal control (C). However, results
f r o mD / E V O O ,D / O O H Fo rD / O O L Fg r o u p sw e r ea l s o
compared with the data of 2,4-D treated group (D). Dur-
ing this study, no sign of toxicity was observed under 2,
4-D treatment at 5 mg/kg. Rats exhibited normal behavior
in comparison to the control group. There were no signifi-
cant differences between tested and control groups of rats
in body weight gain during the experiment (Table 2).
Figure 1 shows that plasma MDA level was doubled in
2,4-D treated group compared to control group. EVOO
and OOHF administrated to rats treated at the same
time with 2,4-D alleviated lipid peroxidation induced by
the herbicide and modulated significantly the level of
MDA in plasma (p <0 . 0 5a n dp < 0.01, respectively).
While lipophilic extract supplemented to 2,4-D treated
rats showed less improvement in the level of MDA
induced by the herbicide. EVOO, OOHF and OOLF
treatment alone did not result in significant changes in
the level of MDA compared to control group.
As for the evaluation of antioxidant enzyme activities,
our results revealed that 2,4-D caused a statistically
significant decrease in SOD, GPx, GR and CAT activ-
ities in rat erythrocytes (p ≤ 0.05) (Table 3). The addi-
tion of EVOO and OOHF to 2,4-D treated group
normalized the levels of these antioxidant enzymes.
Whereas, OOLF administration to 2,4-D treated animals
led to a statistically significant decrease in SOD, GPx,
GR and CAT activities (p < 0.05), compared to the con-
trol value. The change in the activities accounted to
36%, 47%, 41% and 16%, respectively, in rats
Table 1 Mean values of analytical parameters, fatty acids composition (%), oxidative stability and antioxidant content
of extra virgin olive oil (EVOO), hydrophilic fraction (OOHF), lipophilic fraction (OOLF) and standart diet fed to rat
Extra virgin olive oil (EVOO) Lipophilic fraction
(OOLF)
Hydrophilic fraction
(OOHF)
Standard diet
Palmitic acid [%] 10.28 ± 0.04
a 10.40 ± 0.01
a - 11.62 ± 0.85
a
Palmitoleic acid 0.77 ± 0.30
a 0.79 ± 0.60
a - 0.10 ± 0.04
a
Stearic acid 3.39 ± 0.14
a 3.56 ± 0.37
a - 1.15 ± 0.32
b
Oleic acid 64.80 ± 1.99
a 62.58 ± 3.71
a - 29.73 ± 1.12
b
Linoleic acid 14.34 ± 0.90
b 15.04 ± 0.54
b - 53.89 ± 1.49
a
Linolenic acid 0.64 ± 0.04
a 0.68 ± 0.03
a - 0.61 ± 0.02
a
Arachidic acid 0.74 ± 0.05
a 0.78 ± 0.02
a - 0.09 ± 0.04
b
Gadoleic acid 0.62 ± 0.03
a 0.57 ± 0.03
a - 0.14 ± 0.04
b
Behenic acid 2.84 ± 0.37
a 2.87 ± 0.80
a - 0.22 ± 0.10
b
SFA 17.28 ± 0.22
a 17.62 ± 0.42
a - 13.08 ± 0.21
b
MUFA 66.20 ± 2.34
a 63.95 ± 3.07
a - 29.97 ± 1.32
b
PUFA 14.99 ± 0.94
b 15.72 ± 0.57
b - 54.50 ± 2.12
a
MUFA/PUFA 4.43 ± 0.43
a 4.07 ± 0.04
a - 0.54 ± 0.32
b
OSI (h) 9.6
a 4.7
b --
Chlorophylls (mg/kg) 12.65 ± 0.29
a 5.4 ± 0.76
b -N D
b-Carotene (mg/kg) 7.15 ± 0.20
a 5.43 ± 0.08
b -N D
Total polyphenols (mg/kg)* 579.17 ± 71.40
a - 384 ± 23.18
b ND
a-tocopherol (mg/kg) 484.56 ± 11.11
a 491.64 ± 10.36
a - 224 ± 11.86
b
Data are expressed by mean values ± of three independent experiments. SFA: saturated fatty acids; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated
fatty acid; OSI: oxidative stability Index. ND: indicates not determined
Values followed by same letters are not significantly different. (Tukey’s test, p < 0.05)
* As hydroxytyrosol equivalents (mg/kg EVOO)
Table 2 Growth parameters of control and treated rats
Initial body weight
(g)
Final body weight
(g)
Weight gain
(%)
C 216.80 ± 18.10 273.70 ± 27.10 26.16 ± 4.05
D 220.00 ± 11.11 276.70 ± 15.23 25.62 ± 5.66
D/EVOO 222.80 ± 19.03 280.60 ± 19.77 26.21 ± 6.15
D/OOHF 222.60 ± 25.29 279.10 ± 34.74 25.32 ± 5.67
D/OOLF 219.10 ± 16.17 277.40 ± 21.66 26.69 ± 5.90
EVOO 221.30 ± 22.84 271.10 ± 22.96 22.81 ± 6.10
OOHF 225.50 ± 23.10 286.10 ± 25.86 27.08 ± 4.33
OOLF 221.50 ± 30.64 284.50 ± 29.53 29.82 ± 6.85
Data are expressed as means ± SD (n = 10 rats per group). C: controls group,
D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2,
4-D plus hydrophilic fraction, D/OOLF: .2, 4-D plus lipophilic fraction, EVOO:
extra virgin olive oil treated group alone, OOHF: group treated with
hydrophilic fraction of olive oil alone, OOLF: group treated with lipophilic
fraction of olive oil alone. Comparison between groups was made using
ANOVA one way analysis with Bonferroni test.
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did not provoke a significant alteration in the antioxi-
dant enzyme activities compared to control treatment,
except for CAT activity which was significantly
increased after OOHF administration (p <0 . 0 5 ) .
Furthermore, alone OOLF supplementation to rat,
induced a significant reduction in the SOD, GPx, and
GR activities (p < 0.05) and the change accounted to
22% (p < 0.05), 52% (p < 0.01) and 28% (p <0 . 0 5 )
respectively, compared to the control values (Table 3).
Fatty acid composition of erythrocyte membranes
The fatty acid composition of erythrocyte membranes
reflects dietary lipid composition. The changes in ery-
throcyte membranes fatty acids are given in Table 4.
Rats fed a standard diet with 2,4-D tended to have
higher total SFA proportions in erythrocyte than control
rats, and caused by a significant rise of 18:0, 20:0 and
22:0. Whereas total MUFA level was decreased by a sig-
nificant decline of C22:1 and C24:1 (p < 0.05). The pro-
portion of PUFA in total lipids of erythrocyte was
somewhat lowered in 2,4-D treated animals, caused by a
reduction of 20:2 (n-6), 22:4 (n-6), 22:5 (n-3) and 22:6
(n-3). Consequently, a significant decrease of PUFA/SFA
and UFA/SFA ratios was observed in erythrocyte mem-
branes of 2,4-D- treated rats.
In erythrocyte membranes of rat supplemented EVOO
with or without 2,4-D treatment had significantly lower
total SFA levels and higher total MUFA proportions
MDA (µM/g protein)
§§
*
** *
** *
0
0,02
0,04
0,06
0,08
0,1
C D
D/EVOO
D/OOHF
D/OOLF
EVOO
OOHF
OOLF
Figure 1 Plasma MDA level in the treatment groups for 4 weeks. C: controls group, D: 2,4-D treated group at dose 5 mg/kg BW, D/EVOO:
2,4-D (5 mg/kg BW) plus extra virgin olive oil, D/OOHF: .2,4-D plus hydrophilic fraction, D/OOLF: .2,4-D plus lipophilic fraction, EVOO: extra virgin
olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil.
Data are expressed as means ± SD (n = 10 rats per group). Comparison between groups was made using ANOVA with Bonferroni correction (*
p < 0.05; ** p < 0.01 compared to Group D) (
§§ p < 0.01 compared to controls C).
Table 3 Erythrocytes antioxidants enzymes activities in
control and experimental groups
Groups Antioxidant enzyme activity (U/g Hg)
SOD GPx GR CAT
C 644.89 ± 28.41 489.05 ± 24.86 6.11 ±
0.40
1237.27 ± 46.48
D 598.54 ± 18.62
§ 404.22 ±
21.72
§
3.69 ±
1.41
§
1093.22 ± 64.20
§
D/
EVOO
641.56 ± 14.32 485.97 ±
20.56*
5.23 ±
0.84
1368.077 ±
113.67**
D/
OOHF
623.75 ± 71.43 460.18 ± 21.07 5.41 ±
0.69
1210.71 ± 53.11
D/
OOLF
415.07 ±
94.91**
§§
259.18 ±
25.74
§§*
3.62 ±
0.76
§
1044.30 ±
47.37
§§
EVOO 655.47 ± 24.74 476.91 ± 33.58 5.98 ±
0.68*
1180.51 ± 53.82
OOHF 633.78 ± 29.42 472.49 ± 49.48 5.51 ±
0.75
1373.96 ±
71.51**
OOLF 508.52 ± 80.23
§ 235.27 ±
48.06
§§*
4.42 ±
1.00
§
1162.88 ± 85.58
Data are means ± SD; n = 10 for all groups. C: controls group, D: 2, 4-D
treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2, 4-D plus
hydrophilic fraction, D/OOLF: .2, 4-D plus lipophilic fraction, EVOO: extra virgin
olive oil treated group alone, OOHF: group treated with hydrophilic fraction of
olive oil, OOLF: group treated with lipophilic fraction of olive oil. SOD:
Superoxide dismutase, GPx: Glutathione peroxidase, GR: Glutathione
reductase, CAT: catalase.
Comparison between groups was made using ANOVA one way analysis with
Bonferroni test.
** p <.01; * p < .05 (compared to Group D)
§§ p < .01;
§ p < .05 (compared to controls C).
Nakbi et al. Lipids in Health and Disease 2010, 9:89
http://www.lipidworld.com/content/9/1/89
Page 4 of 10than controls and 2,4-D treated rats. This effect was
mainly due an increase in 16:1, 18:1, 20:1 and 24:1 at
the extent of 16:0, 18:0 and 20:0 (Table 4). Total lipids
in erythrocytes from EVOO supplemented rats treated
or not with 2,4-D tended to have a lower proportion of
PUFA than those from controls and 2,4-D treated
groups, which was due to a significant reduction in 20:4
(n-6), 22:4 (n-6), 22:5 (n-3) and 22:6 (n-3) levels.
Furthermore, the saturation indexes (UFA/SFA)
and (PUFA/SFA) were increased in erythrocyte mem-
branes compared to 2,4-D treated group. While
polyunsaturated to monounsaturated fatty acids (PUFA/
MUFA) tended to be lowered over 4 weeks (Table 4).
No differences were found among hydrophilic and
lipophilic fractions administered with or without 2,4-D
groups for fatty acid composition of the erythrocyte
membranes compared to controls except for the OOLF
group. This latter group showed a significant raise of
MUFA proportion. The (UFA/SFA) and (PUFA/SFA)
ratios were somewhat elevated in erythrocyte mem-
branes of rats supplemented hydrophilic or lipophilic
fractions with or without 2,4-D treatment than that of
Table 4 Erythrocyte membranes fatty acid composition of control and treated rats
FA% C D D/EVOO D/OOHF D/OOLF EVOO OOHF OOLF
C14:0 2.30 ± 0.36 2.19 ± 0.49 2.08 ± 0.34 2.18 ± 0.33 2.26 ± 0.43 2.23 ± 0.34 1.94 ± 0.28 1.93 ± 0.30
C16:0 25.96 ± 1.32 26.44 ± 1.90 22.34 ±
1.71
§§**
25.15 ± 1.89 24.17 ± 1.87 20.31 ± 1.15
§§** 24.41 ± 1.68 20.91 ±
1.74
§§**
C18:0 16.54 ± 3.30 22.96 ± 1.26
§ 19.78 ± 1.89* 20.94 ± 0.96* 20.58 ± 2.03* 15.37 ± 1.34** 19.27 ± 1.24** 20.80 ± 3.50*
C20:0 0.20 ± 0.04 0.36 ± 0.09
§§ 0.21 ± 0.06** 0.19 ± 0.08** 0.41 ± 0.08
§§ 0.22 ± 0.05** 0.21 ± 0.12** 0.39 ± 0.05
§§
C22:0 1.04 ± 0.24 1.65 ± 0.47
§ 0.86 ± 0.21** 1.21 ± 0.32 1.24 ± 0.40 1.14 ± 0.26 1.53 ± 0.38 1.16 ± 0.15
C24:0 0.94 ± 0.26 1.11 ± 0.36 0.92 ± 0.37 0.54 ± 0.21* 1.13 ± 0.44 0.95 ± 0.42 0.47 ± 0.21
§** 1.12 ± 0.63
ΣSFA 46.98 ±
4.48
54.71 ± 3.26
§ 46.19 ± 4.49* 50.21 ± 3.75* 49.79 ± 3.32 40.22 ± 2.69
§** 47.83 ± 3.76* 46.31 ± 4.05*
C14:1 0.55 ± 0.14 0.71 ± 0.15 0.76 ± 0.16 0.74 ± 0.11 0.54 ± 0.12 0.73 ± 0.09 0.55 ± 0.12 0.64 ± 0.10
C16:1 0.40 ± 0.06 0.33 ± 0.07 0.63 ± 0.07
§** 0.53 ± 0.09* 0.38 ± 0.05 0.57 ± 0.05
§** 0.51 ± 0.05** 0.34 ± 0.06
C18:1 17.15 ± 0.19 15.67 ± 1.10 19.64 ± 1.33* 15.54 ± 1.17 16.08 ± 1.35 21.88 ± 0.96
§§** 17.74 ± 0.37 19.30 ± 1.14
§*
C20:1 0.23 ± 0.07 0.20 ± 0.06 1.06 ± 0.18
§§** 0.40 ± 0.12
§* 0.22 ± 0.08 0.42 ± 0.12
§* 1.35 ± 0.40
§§** 0.38 ± 0.05
§*
C22:1 0.18 ± 0.04 0.09 ± 0.03
§ 1.13 ± 0.23
§ 0.46 ± 0.11
§§ 0.20 ± 0.03** 0.87 ± 0.24 1.5 ± 0.24
§§** 1.67 ± 0.56
§*
C24:1 1.62 ± 0.16 0.89 ± 0.25
§ 1.97 ± 0.56* 1.44 ± 0.39 1.37 ± 0.39 2.27 ± 0.46* 1.27 ± 0.28 1.66 ± 0.73
ΣMUFA 20.13 ±
2.89
17.89 ± 0.66
§ 25.19 ±
0.40
§**
19.11 ± 1.60 18.79 ± 1.76 26.74 ±
1.28**
§§
22.92 ±
0.65**
23.99 ±
1.63
§**
C18:2 ω6 11.76 ± 0.84 11.19 ± 0.82 11.41 ± 0.74 11.53 ± 0.48 11.50 ± 0.21 11.58 ± 0.66 11.83 ± 1.32 11.44 ± 0.39
C18:3w3ALA 0.36 ± 0.09 0.39 ± 0.1 0.48 ± 0.04 0.39 ± 0.05 0.49 ± 0.04 0.43 ± 0.09 0.40 ± 0.18 0.65 ± 0.14
§§*
C20:2 ω6 0.29 ± 0.10 0.52 ± 0.20
§ 0.36 ± 0.13 0.30 ± 0.10* 0.79 ± 0.18
§§* 0.36 ± 0.10 0.34 ± 0.11 0.57 ± 0.17
§§
C20:3 ω6 0.40 ± 0.14 0.24 ± 0.07 0.41 ± 0.17 0.29 ± 0.10 0.60 ± 0.24* 0.56 ± 0.25* 0.52 ± 0.14* 0.63 ± 0.37*
C20:4 ω6 14.39 ± 2.03 14.45 ± 1.81 11.35 ±
1.70
§§**
13.57 ± 1.85 12.81 ± 1.47 11.20 ± 1.48
§§** 14.17 ± 1.82 12.76 ± 1.51
C20:5w3EPA 0.31 ± 0.16 0.35 ± 0.19 0.39 ± 0.02 0.46 ± 0.12 0.33 ± 0.14 0.73 ± 0.12
§§* 0.63 ± 0.12
§§* 0.73 ± 0.14
§§*
C22:4 ω6 0.82 ± 0.19 0.32 ± 0.08
§§ 0.67 ± 0.05** 1.08 ± 0.15
§** 1.21 ± 0.19
§** 1.05 ± 0.30* 0.68 ± 0.16* 1.25 ± 0.23
§**
C22:5w3DPA 0.67 ± 0.24 0.18 ± 0.07
§§ 0.80 ± 0.15** 0.30 ± 0.17
§ 0.23 ± 0.14
§ 1.03 ± 0.27
§** 0.29 ± 0.16
§ 0.29 ± 0.15
§
C22:6w3DHA 1.34 ± 0.31 0.20 ± 0.07
§§ 0.94 ± 0.20** 1.98 ± 0.46
§** 1.48 ± 0.43** 1.84 ± 0.42** 1.36 ± 0.25** 1.05 ± 0.26**
ΣPUFA 30.34 ±
3.14
27.84 ± 0.81 26.81 ± 1.93
§ 29.90 ± 1.85 29.44 ± 0.97 28.78 ± 0.75 30.22 ± 1.73* 29.37 ± 0.74
ΣUFA 41.77 ±
1.07
35.29 ±
0.64
§§
38.99 ± 1.49
§* 39.96 ±
0.89
§§**
35.96 ±
1.77
§§
41.85 ± 1.41** 36.95 ±
1.13
§§
44.22 ± 1.87**
PUFA/MUFA 1.50 ± 0.10 1.55 ± 0.11 1.06 ± 0.12
§§** 1.56 ± 0.15 1.56 ± 0.13 1.07 ± 0.10
§§** 1.31 ± 0.04 1.22 ± 0.07
§§**
PUFA/SFA 0.64 ± 0.05 0.50 ± 0.05
§§ 0.58 ± 0.05*
§ 0.59 ± 0.03* 0.59 ± 0.04* 0.71 ± 0.03
§** 0.63 ± 0.04** 0.63 ± 0.07**
UFA/SFA 0.88 ± 0.06 0.64 ± 0.05
§§ 0.84 ± 0.08* 0.79 ± 0.04 0.72 ± 0.10 1.04 ± 0.18
§** 0.77 ± 0.08 0.95 ± 0.05**
Data are means ± SD; n = 10 for all groups. C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2, 4-D plus hydrophilic
fraction, D/OOLF: 2,4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF:
group treated with lipophilic fraction of olive oil.
SFA: Saturated fatty acid, MUFA: monounsaturated fatty acid, PUFA: polyunsaturated fatty acid, UFA: unsaturated fatty acid
** p <.01; *p < .05 (compared to Group D);
§§ p<. 0 1 ;
§ p < .05 (compared to controls C)
Comparison between groups was made using ANOVA one way analysis with Bonferroni test
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ratio was decreased.
Discussion
T h ep r e s e n ts t u d yi n v e s t i g a t e s the potential protective
effect of EVOO and its fractions (hydrophilic and lipo-
philic) supplementation to animals treated with 2,4-D
pesticide. The increase of MDA level and the impair-
ment of antioxidant enzyme activities clearly indicated
that 2,4-D had the potency to cause oxidative damage in
erythrocytes. In fact, it has been previously reported that
a c u t ee x p o s u r et o2 , 4 - Dm a yi n d u c eo x i d a t i v es t r e s si n
rats [11]. The authors found that the administration of
1 . 5a n d3m g / do f2 , 4 - Dd u r i n g2 5d a y sm i g h ta f f e c t
antioxidant potential enzymes, the activity of hepatic
damage enzymes and lipid peroxidation. Other investi-
gators have examined in vitro effects of 2,4-D on the
generation of ROS, either at the mitochondrial level in
hepatocytes or in red blood cells [3,6]. However, it has
been shown that superoxide radical product can directly
inhibit the activities of enzymes SOD, GPx and CAT,
likewise, singlet oxygen and peroxyl radicals have been
shown to inhibit SOD and CAT activities [42,43]. These
observations may be explaining the significant decrease
of SOD, GPx, GR and CAT activities in erythrocytes of
2,4-D-treated rats compared to controls. Furthermore, it
was known that 2,4-dichlorophenol strongly decreases
the level of reduced glutathione [44] and depletes the
activity of the enzymes probably by disturbing their ter-
tiary structure [5,45].
The co-administration of EVOO or OOHF counter-
acted the deleterious effects of 2,4-D by scavenging or
neutralizing ROS. In fact, a marked decrease of MDA
level and an increase of antioxidant enzyme activities
were observed in EVOO and OOHF supplemented
groups. However, despite its content in a- tocopherol,
oral administration of OOLF with 2,4-D for 4 weeks did
not show a protective role against oxidative stress
caused by 2,4-D in erythrocyte rats. Therefore, we can
s u g g e s tt h a tt h ep r o t e c t i v ee f f e c t so fE V O Oa r em o s t l y
attributed to the antiperoxidative property of its polar
fraction. Indeed, in vitro and ex vivo models, olive oil
phenolic compounds were proved to have antioxidant
properties, higher than that of vitamin E, on lipids and
DNA oxidation [46,47]. This study reported that olive
oil phenolic compounds are also able to enhance the
mRNA transcription of the antioxidant enzyme glu-
tathione peroxidase. Furthermore, other studies have
demonstrated a higher resistance to oxidation of LDL
obtained from animals fed virgin olive oil, as compared
to LDL separated from animals that were only adminis-
tered an equivalent amount of oleic acid as either trio-
lein [48] or dietary non-tocopherol antioxidants present
in EVOO [49]. In our previous study, we found that
EVOO with a higher phenolic content seemed to have
beneficial effects on LDL particles oxidizability [50].
Moreover, it has been reported that phenolic com-
pounds are able to interact with biological systems and
to act as bioactive molecules; in particular they are
important inhibitors of lipid peroxidation [51] and are
believed to be effective through their free radical scaven-
ging and metal chelating properties [52]. Several studies
have demonstrated the ability of olive oil to inhibit oxi-
dative stress in the liver through various mechanisms
[53]. A study in our laboratory showed that oral supple-
mentation of olive oil to rats administered ethanol
chronically restored damage caused in the liver by inhi-
biting lipid peroxidation along with improving of the
activities of enzymes [54].
The antioxidants enzymes (SOD, GPx, GR and CAT)
limit the effects of oxidant molecules on tissues and are
active in the defence against oxidative cell injury by
means of their being free radical scavengers [55]. These
enzymes work together to eliminate ROS where small
deviations in physiological concentrations may have a
dramatic effect on the resistance of cellular lipids, pro-
teins and DNA to oxidative damage. Lipid peroxidation
is the process of oxidative degradation of PUFA and its
occurrence in biological membranes causes impaired
membrane function, structural integrity, decrease in
membrane fluidity and inactivation of a several mem-
brane bound enzymes [56]. From the experiment
d e s c r i b e da b o v e ,i ti sq u i t ee v i d e n tt h a tt h ef a t t ya c i d
composition of the erythrocyte membranes can be
altered by 2,4-D exposure during 4 weeks. Knowing that
PUFAs are more susceptible to peroxidation resulting in
MDA formation in mammalian tissues [57] as a conse-
quence a significant increase of SFA and decrease of
MUFA and PUFA proportions were observed in ery-
throcyte membranes of 2,4-D treated rats. In fact, due
to their peculiar structure, that is the presence of one or
more double bonds, UFA are more susceptible to free
radical damage. Consequently, a significant decrease in
the PUFA/SFA and UFA/SFA ratios were seen in ery-
throcyte membranes of 2,4-D exposure rats. These
results may explain the higher amounts of MDA
observed in 2,4-D treated group.
Whereas, EVOO supplemented to rats treated or not
with 2,4-D significantly reduced the proportion of SFA
and enhanced the level of MUFA, mostly in the form of
oleic acid, in erythrocyte membranes of rats. PUFA pro-
portion was somewhat decreased compared to control
group. Consequently, a lower amount of MDA was
observed in these groups. This modification showed the
protecting effects of the tested compounds supplemen-
ted diet which counteracted the deleterious effects of
the herbicide, by their supplement in MUFA, phenolic
compounds and vitamins. In fact, most of the studies
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rich diet on LDL oxidation parameters have found a
higher resistance of LDL particles to oxidation after the
consumption of MUFA-rich diet [58]. Therefore the dif-
ferences in erythrocyte membranes’ fatty acid composi-
tion reflected the different fatty acid compositions of the
diets and may be responsible for the differences in their
tendency to lipid peroxidation.
Conclusion
The results obtained from this study illustrated the oxi-
dative damage and the changes of the fatty acid profile
in erythrocyte membranes in rats resulting from suba-
cute 2,4-D exposure. The dietary supplementation of
extra virgin olive oil counteracted the damage effect of
the pesticide by the enhancement of antioxidant defence
system and the decline of the lipid peroxidation.
Furthermore, the resistance to lipid peroxidation of ery-
throcyte membranes is modulated by both dietary fatty
acid composition and antioxidant content. Conse-
quently, the fatty acid composition of erythrocytes can
be influenced by the type of dietary fat in rats.
Methods
Materials
2, 4-D commercial formulation (Désormone Lourd) con-
sisting of 600 g/l 2,4-D Ester butylglycol, register num-
ber H.96064 (SEPCM), available in Tunisia, was used in
experimentation (Figure 2). 2-Thiobarbituric acid (TBA)
was obtained from Sigma Chemicals Co (Taufkirchen,
Germany). Folin-Ciocalteu phenol reagent was pur-
chased from Fluka Biochemika (Buchs, Switzerland). All
other used chemicals were of analytical grade and were
obtained from Sigma Chemicals Co or Merck (Darm-
stadt, Germany).
Oil sample analysis
The EVOO used in this experiment was obtained from
Chétoui cultivar grown in the North of Tunisia. The
OOHF were extracted from EVOO by Montedoro et al.
(1992) method [59]. However, the OOLF was obtained
from EVOO as follows: EVOO was homogenized for 1
min with water (1:1, v/v) and the oil was separated by
centrifugation. This procedure was repeated six times.
Then, the oil fraction (OOLF) was filtered through a
cellulose acetate membrane.
The fatty acid methyl esters (FAME) were prepared
by dissolving 0.1 g of EVOO or OOLF in 2 ml of hep-
t a n ea n d0 . 2m lo fK O H( 0 . 2N )i nm e t h a n o la n di n c u -
bated for 1 hour. Chromatographic separation was
carried out using a Hewlett-Packard (HP 5890) chro-
matograph (Hewlett-Packard Ca Palo Alto, Calif USA),
a split/splitless injector, and a flame ionisation detector
(FID) linked to an HP Chemstation integrator. A
fused-silica capillary column, HP-Innowax (30 m ×
0.25 mm × 0.25 µm), was used with nitrogen as the
carrier gas at a flow rate of 1 ml/min; flame ionisation
detection temperature 280°C; injector temperature
250°C; oven temperature programmed from 170 to
270°C at a rate of 5°C per min. Results were expressed
as relative percent of total area [60].
Oxidation stability was evaluated by the Rancimat
apparatus (Model 743, Metrohm Schweiz AG, Zofingen,
Switzerland) using 3 g of oil sample heated to 120°C
with 20 l/h air flow [61]. Stability was expressed as oxi-
dation induction time (hours).
Carotenoids and chlorophylls (mg/kg oil) were deter-
mined at 470 and 670 nm, respectively, in cyclohexane
using the specific extinction values according to the
method of Minguez-Mosquera et al. [62].
The phenolic compounds were extracted, estimated
colorimetrically at 765 nm using the Folin-Ciocalteau
reagent, and expressed as hydroxytyrosol equivalents as
reported by Montedoro et al. [59].
For the a-tocopherol analysis, the sample was diluted
with n-hexane (1:10), the mixture was vortexed and 200 μl
was transferred to a test tube containing 600 μl of metha-
nol and 200 μlo fi n t e r n a ls t a n d a r d( 3 0 0μg/ml). HPLC
separation was carried out on a Hewlett-Packard system
(Waldbronn, Germany) equipped with a HP-1100 pump, a
Rheodyne model 7725 injector (Cotati, CA, USA, loop
volume 20 μl), a HP-1200 M multi-array detector and a
Supelcosil ODS-2 column (150 × 4.5 mm id., film thick-
ness 5 μm) [63].
Diets and Animal treatment
Male adult Wistar rats (Central Pharmacy, Tunisia),
weighing about 200 to 230 g, were housed at 22 ± 3°C,
with 12- hour light-dark periods, a 40% minimum rela-
tive humidity and free access to water and standard diet
(protein 17%, carbohydrate 62%, lipids 4%, ash 7%, and
moisture 10%) (SICO, Sfax Tunisia). All the breeding
phases and experiments were conformable to the rules
of the Tunisian Society for the Care and Use of Labora-
tory Animals. All experiments were conducted at the
Figure 2 Chemical structure of 2,4-D.
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Page 7 of 10animal facilities of the faculty of Medicine, Monastir;
w i t ht h ea p p r o v a lo ft h eF a c u l t yo fM e d i c i n eE t h i c s
committee.
After acclimatization to the laboratory conditions for
one week, the animals were divided into 8 groups of 10
animals each. Group C included the control animals and
received 1 ml of distilled water gavages daily and fed
with a standard diet. Group D was gavaged a daily dose
of 2,4-D at a concentration of 5 mg/kg body weight (b.
w.) and fed with the standard diet. Group D/EVOO was
treated simultaneously with 2,4-D at a dose of 5 mg/kg
b.w. and EVOO (300 μl) daily by gavage. Groups D/
OOHF and D/OOLF received daily 5 mg/kg b.w. of 2,4-
D followed by hydrophilic fraction (HF) supplementa-
tion (1 ml) and lipophylic fraction (LF) (300 μl) by
gavage, respectively. The animals in EVOO, OOHF and
OOLF groups were given EVOO (300 μl), hydrophilic
fraction (1 ml; the same amount of phenols that we
found in 300 μl of oil = 0.16 mg) and lipophilic fraction
(300 μl), respectively.
Each group was kept on the treatment for 4 weeks.
Water and food consumption and the individual animal
body-weight were recorded daily throughout the experi-
ment. At the end of the experimental period, the rats
were kept fasting overnight and were sacrificed under
diethyl ether anaesthesia.
Blood collections
Blood was drawn by cardiac puncture and collected into
evacuated tubes containing EDTA solution as anticoagu-
lant for determination of haemoglobin (Hb) and heparin
for dosage of antioxidant enzyme activities. Erythrocytes
were separated from blood plasma by centrifugation
(600 × g,1 0m i n )a t4 ° Ca n dw a s h e dt h r e et i m e sw i t h
cold phosphate-buffered saline (PBS; 150 mmol l
-1 NaCl,
1.9 mmol l
-1 NaH2PO4,8 . 1m m o l
-1 Na2HPO4,p H7 . 4
and stored at -80°C in aliquots until the analysis. The
Haemoglobin (Hb) assay is based on the colorimetric
cyanomethemoglobin method according to Drabkin [64].
Biochemical analysis
Plasma malondialdehyde (MDA) levels were determined
as described previously by Yagi [65]. 125 μlo fs e r u m
were homogenized by sonication with 50 μlo fT B S ,
125 μl of TCA-BHT in order to precipitate proteins and
then centrifuged (1000 g, 10 min, 4°C). 200 μl of super-
natant were mixed with 40 μl of HCl (0.6 M) and 160 μl
of TBA dissolved in Tris and the mixture was heated at
80°C for 10 min. The absorbance of the resultant super-
natant was read at 530 nm. The TBA-rm amount was
calculated using a 156 mM
-1 cm
-1 extinction coefficient.
Antioxidant enzyme activities were analyzed using a
BioRad UV-Visible spectrophotometer with a “kinetics”
program (BioRad, Mares la Coquette, France). The
measurement of SOD, GPx and GR activities in erythro-
cytes were performed by the commercially available diag-
nostic kits supplied by Randox Laboratories. CAT activity
was measured at 25°C according to Aebi’s method [66], by
measuring H2O2 concentration decrease at 240 nm.
Fatty acids were analyzed as fatty acid methyl esters
(FAMEs) by gas chromatography analysis as previously
described [67]. Briefly, total lipids were extracted from
the erythrocytes by the modified method mentioned by
Folch et al [68] using a chloroform-methanol (2:1, vol/
vol) solvent system containing 0.01% butylated hydroxy-
toluene as antioxidant. Aliquots of the total lipids were
converted into the methyl esters through a mixture of
methanol-hexane-H2SO4 (75:25:1, vol/vol) as the methy-
lation reagent, at 90°C for 90 min. FAMEs were ana-
lyzed in duplicate, and 1 μl of each sample was injected
into the gas chromatography system (Hewlett Packard,
Palo Alto, Calif.) equipped with a flame ionization
detector and a polar fused silica capillary column HP-
Innowax with cross-linked PEG, Carbowax 20 M (30 m
× 0.25 mm ID and 0.25 μm as film thickness). The oven
temperature was programmed to increase from 180°C to
250°C at a rate of 10°C/min, and the injector and detec-
tor temperatures were 220°C and 280°C, respectively.
Fatty acid methyl esters were identified by comparing
their retention times with those of individual standards.
Statistical analysis
The data were analyzed using the Statistical Package for
Social Sciences (SPSS) programme, release 11.0 for Win-
dows (SPSS, Chicago, IL, USA). In each assay, the
experimental data represent the mean of ten indepen-
dent assays ± standard deviations. The results were ana-
l y z e db ya nA N O V Aw i t haB o n f e r r o n ic o r r e c t i o ni n
order to perform multiple comparisons. Tukey’s test was
used to determine any significant differences between
analytical parameters of supplemented diets. The statis-
tical significance was set at p < 0.05.
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